Back to top

LIBerate-Kids: Medpace Backs New Pediatric Cholesterol Study With Lerodalcibep

Medpace Holdings Inc ($MEDP) announced an update on their ongoing clinical study. The LIBerate-Kids trial, officially titled “Study to Evaluate the...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Medpace Holdings, Inc. (MEDP)